Rivpra Formulation

Haridwar, India Founded: 2005 • Age: 21 yrs
Manufacturer of generic tablets, capsules, and liquid

About Rivpra Formulation

Rivpra Formulation is a Healthcare company based in Haridwar (India) founded in 2005. Manufacturer of generic tablets, capsules, and liquid. It operates on a Traditional Pharmaceuticals model. The company has 91 employees. Its chief executive, as recorded, is Aloke Ghosh. Its Indian entity Rivpra Formulation Private Limited reported revenue of β‚Ή215 Cr. Rivpra Formulation offers products and services including Rivpra Formulation Platform. Its focus areas include Traditional Pharmaceuticals, Generics, Companies and Diversified.

Company details

Rivpra Formulation, led by Vibhor Rastogi as Director, Aloke Ghosh as CEO, specializes in providing healthcare solutions, traditional pharmaceuticals, traditional pharmaceuticals, and providing healthcare solutions. Manufacturer of generic tablets, capsules, and liquid. The team drives innovation, quality service, and sustainable practices to achieve excellence and client satisfaction.

Key Metrics
  • Annual Revenue
    ₹215 Cr

    FY 2025 · -7% YoY

  • Net Profit
    ₹21.11 Cr

    FY 2025 · 10% margin

  • EBITDA
    ₹31.29 Cr

    FY 2025 · 15% margin

  • Employee Count
    91

Products & Services of Rivpra Formulation

Rivpra Formulation offers a comprehensive portfolio of products and services, including Rivpra Formulation Platform.

Rivpra Formulation Platform
Healthcare

Manufacturer of generic tablets, capsules, and liquid

Board of directors of Rivpra Formulation Private Limited (Rivpra Formulation)

Rivpra Formulation Private Limited is the primary company behind Rivpra Formulation. The board of Rivpra Formulation Private Limited currently have 2 directors; the longest-serving is Vibhor Rastogi, appointed in 2005. 4 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Vibhor Rastogi
DIN 00523947
Director21 Nov 200521 yrsRivpra Formulation Private Limited
Ram Prakash Rastogi
DIN 01929524
Director28 Mar 201511 yrs 7 moRivpra Formulation Private Limited

People of Rivpra Formulation

2 people are tracked at Rivpra Formulation (2 in leadership); the tracked headcount is 91.

NameRoleGroup
DirectorLeadership
Aloke Ghosh
CEOLeadership
Premium access

Complete people profiles for Rivpra Formulation

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Rivpra Formulation

Figures of Rivpra Formulation Private Limited, the primary company behind Rivpra Formulation, for FY 2025. Revenue was ₹215 Cr (-7% year on year). Net profit was ₹21.11 Cr (10% margin). EBITDA was ₹31.29 Cr (15% margin). Revenue has grown at a compounded annual rate of +7% over three years and +14% over five years.

  • ₹215 CrRevenue · FY 2025 · -7% YoY
  • ₹21.11 CrNet profit · 10% margin
  • ₹31.29 CrEBITDA · 15% margin
  • ₹4.00 CrPaid-up capital
  • 91Employees (provident fund records)
  • +7%Revenue CAGR, 3 years
  • +14%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Rivpra Formulation Private Limited are on its company page.

Premium access

Detailed financial statements for Rivpra Formulation

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Rivpra Formulation

Premium access

Complete news archive for Rivpra Formulation

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rivpra Formulation

Rivpra Formulation was founded in 2005.

Rivpra Formulation is headquartered in Haridwar, India. It is registered at Haridwar, Uttarakhand, India.

Aloke Ghosh is the CEO of Rivpra Formulation, as recorded in our data.

Rivpra Formulation has 91 employees.

The primary company behind Rivpra Formulation, Rivpra Formulation Private Limited, reported revenue of β‚Ή215 Cr for FY 2025, down 7% year on year.

Rivpra Formulation, led by Vibhor Rastogi as Director, Aloke Ghosh as CEO, specializes in providing healthcare solutions, traditional pharmaceuticals, traditional pharmaceuticals, and providing healthcare solutions. Manufacturer of generic tablets, capsules, and liquid. The team drives innovation, quality service, and sustainable practices to achieve excellence and client satisfaction.

Rivpra Formulation offers Rivpra Formulation Platform.

Rivpra Formulation operates through Rivpra Formulation Private Limited.

The legal entities of Rivpra Formulation currently have 2 directors, including Vibhor Rastogi, Ram Prakash Rastogi.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available